D. Stirling

1.2k total citations
26 papers, 889 citations indexed

About

D. Stirling is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, D. Stirling has authored 26 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in D. Stirling's work include BRCA gene mutations in cancer (7 papers), Reproductive Physiology in Livestock (6 papers) and Ovarian cancer diagnosis and treatment (4 papers). D. Stirling is often cited by papers focused on BRCA gene mutations in cancer (7 papers), Reproductive Physiology in Livestock (6 papers) and Ovarian cancer diagnosis and treatment (4 papers). D. Stirling collaborates with scholars based in United Kingdom, United States and Netherlands. D. Stirling's co-authors include Mary Porteous, E R Simpson, Ronald R. Magness, Edward Simpson, Michael R. Waterman, Ronald K. Stone, Matti Waterman, A Shenton, D. Gareth Evans and Charlie Gourley and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Biochemical Journal.

In The Last Decade

D. Stirling

26 papers receiving 860 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Stirling United Kingdom 14 337 219 206 153 143 26 889
Jerome F. Strauss United States 14 227 0.7× 115 0.5× 239 1.2× 156 1.0× 75 0.5× 16 909
Takashi Samoto Japan 17 110 0.3× 402 1.8× 228 1.1× 318 2.1× 16 0.1× 22 1.3k
Jana Březinová Czechia 20 101 0.3× 199 0.9× 300 1.5× 280 1.8× 486 3.4× 94 1.1k
Dijana Plaseska‐Karanfilska North Macedonia 14 262 0.8× 177 0.8× 311 1.5× 100 0.7× 103 0.7× 102 805
Eric Lee United States 11 138 0.4× 83 0.4× 345 1.7× 303 2.0× 22 0.2× 28 1.2k
H Yaneva France 11 159 0.5× 65 0.3× 157 0.8× 62 0.4× 50 0.3× 19 664
Andrew N. Stephens Australia 17 84 0.2× 343 1.6× 241 1.2× 133 0.9× 14 0.1× 35 811
Jiasen Xu China 21 99 0.3× 229 1.0× 425 2.1× 330 2.2× 15 0.1× 40 1.1k
Alicia Quiñonero Spain 20 124 0.4× 599 2.7× 298 1.4× 392 2.6× 24 0.2× 50 1.4k
Susanne Eder Austria 17 98 0.3× 56 0.3× 236 1.1× 163 1.1× 186 1.3× 41 801

Countries citing papers authored by D. Stirling

Since Specialization
Citations

This map shows the geographic impact of D. Stirling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Stirling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Stirling more than expected).

Fields of papers citing papers by D. Stirling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Stirling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Stirling. The network helps show where D. Stirling may publish in the future.

Co-authorship network of co-authors of D. Stirling

This figure shows the co-authorship network connecting the top 25 collaborators of D. Stirling. A scholar is included among the top collaborators of D. Stirling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Stirling. D. Stirling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stirling, D., et al.. (2019). Mainstreaming BRCA1 and BRCA2 testing: an interview study of healthcare professionals' views. European Journal of Human Genetics. 27. 664–665. 1 indexed citations
2.
3.
Hallowell, Nina, et al.. (2019). Moving into the mainstream: healthcare professionals’ views of implementing treatment focussed genetic testing in breast cancer care. Familial Cancer. 18(3). 293–301. 47 indexed citations
4.
Spiliopoulou, Pavlina, C. Bell, D. Stirling, et al.. (2018). Routine germline BRCA1 and BRCA2 testing in patients with ovarian carcinoma: analysis of the Scottish real‐life experience. BJOG An International Journal of Obstetrics & Gynaecology. 125(11). 1451–1458. 19 indexed citations
5.
Porteous, Mary, D. Stirling, Julia Lawton, et al.. (2018). Patients’ Views of Treatment‐Focused Genetic Testing (TFGT): Some Lessons for the Mainstreaming of BRCA1 and BRCA2 Testing. Journal of Genetic Counseling. 27(6). 1459–1472. 22 indexed citations
6.
Walsh, Kathy, William Wallace, Rachel Butler, et al.. (2014). A cautionary lesson on the use of targeted methods for EGFR mutation analysis: a case report. Journal of Clinical Pathology. 67(8). 734–735. 8 indexed citations
7.
Anderson, Julia A. M., et al.. (2011). Plasma microparticles are not elevated in fresh plasma from patients with gynaecological malignancy — An observational study. Gynecologic Oncology. 123(1). 152–156. 3 indexed citations
8.
McGorum, B. C., et al.. (2009). Vitamin K Deficiency Bleeding in a Standardbred Colt. Journal of Veterinary Internal Medicine. 23(6). 1307–1310. 3 indexed citations
9.
Slight, Robert, R. Brian Ferguson, D. Stirling, D. B. L. McClelland, & Pankaj S. Mankad. (2008). Experience with sodium fluorescein flow cytometry in the determination of red cell volume. International Journal of Laboratory Hematology. 31(2). 233–235. 3 indexed citations
10.
Evans, D. Gareth, Katja N. Gaarenstroom, D. Stirling, et al.. (2008). Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers. Journal of Medical Genetics. 46(9). 593–597. 96 indexed citations
12.
Chalmers, Elizabeth, SA Brown, David Keeling, et al.. (2007). Early factor VIII exposure and subsequent inhibitor development in children with severe haemophilia A. Haemophilia. 13(2). 149–155. 128 indexed citations
13.
Stirling, D., D. Gareth Evans, Gabriella Pichert, et al.. (2005). Screening for Familial Ovarian Cancer: Failure of Current Protocols to Detect Ovarian Cancer at an Early Stage According to the International Federation of Gynecology and Obstetrics System. Journal of Clinical Oncology. 23(24). 5588–5596. 117 indexed citations
14.
Bramley, T. A., D. Stirling, G. S. Menzies, & D. T. Baird. (2004). Reduced LH sensitivity in vivo and in vitro of corpora lutea induced during anoestrus by GnRH, and during the late breeding season, in Scottish Blackface ewes. Journal of Endocrinology. 183(3). 517–526. 2 indexed citations
16.
Kerr, Ron, et al.. (2003). Effects of acute liver injury on blood coagulation. Journal of Thrombosis and Haemostasis. 1(4). 754–759. 58 indexed citations
17.
Conley, Alan J., Judith R. Head, D. Stirling, & J. Ian Mason. (1992). Expression of steroidogenic enzymes in the bovine placenta and fetal adrenal glands throughout gestation.. Endocrinology. 130(5). 2641–2650. 45 indexed citations
18.
Doody, Kevin J., Edwin D. Lephart, D. Stirling, et al.. (1991). Expression of mRNA species encoding steroidogenic enzymes in the rat ovary. Journal of Molecular Endocrinology. 6(2). 153–162. 38 indexed citations
19.
Stirling, D., Michael R. Waterman, & Edward Simpson. (1991). Expression of mRNA encoding basic fibroblast growth factor (bFGF) in bovine corpora lutea and cultured luteal cells. Reproduction. 91(1). 1–8. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026